Karin Förster

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 298 citations

Asthma, Rheumatology, Extension Trial +10

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling et al. · The Lancet Respiratory Medicine · 2023 · 127 citations · Full text

Asthma, Rheumatology, Allergy +9

Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study.

A. Reichelt, Karin Förster, Michael J. M. Fischer et al. · PubMed · 1994 · 91 citations

Rheumatoid Disorder, Pharmacology, Double-blind Study +15

The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD

A. Kirsten, Karin Förster, E. Radeczky et al. · Pulmonary Pharmacology & Therapeutics · 2015 · 86 citations

Advanced Lung Disease, Pulmonary Pharmacology, Pulmonary Medicine +6

Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD

H. Worth, Karin Förster, Göran Eriksson et al. · Respiratory Medicine · 2010 · 37 citations

Exercise Tolerance, Exercise, Physiology +6